Actively Recruiting
Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.
Led by Aligarh Muslim University · Updated on 2024-10-24
300
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Postpartum hemorrhage continues to be the leading cause of maternal morbidity and mortality. Globally, it is responsible for 25% of all pregnancy-related deaths. PPH is unpredictable and may occur in the absence of risk factors. Tranexamic acid is an antifibrinolytic proven to reduce blood loss and transfusion requirements for various surgeries. This study aims to explore the effectiveness of tranexamic acid as an adjunct to other uterotonics before the Caesarian Section.
CONDITIONS
Official Title
Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women undergoing cesarean delivery (elective or emergency) during the study period
- Willing to participate in the study after understanding the concept
You will not qualify if you...
- Critically ill patients
- Not willing to give consent to participate in the study
- Diagnosed with a ruptured uterus or undergoing cesarean hysterectomy during operation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ASJSATDS Medical College
Fatehpur, Uttar Pradesh, India, 212601
Actively Recruiting
Research Team
M
MUAZZAM HASAN, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here